Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-DE-111810-3   |   PDF   |   Print   |  
| 
published: 03 Mar 2017 last updated: 23 Nov 2020
General Information
6786-01-0100 (adv. 42010.0100); Summary of the risk assessment of a deliberate release (field trial) of genetically modified grape vine (Vitis vinifera) different independent lines, issued by the German Competent Authority
EN
15 Jul 1999
Risk assessment details
  • Grape vine modified for resistance to fungal pathogens
    | Bundesanstalt für Züchtungsforschung an Kulturpflanzen(BAZ) | Resistance to antibiotics (Kanamycin, Neomycin), Resistance to diseases and pests (Fungi)
  • Grape vine modified for resistance to fungal pathogens
    | Bundesanstalt für Züchtungsforschung an Kulturpflanzen(BAZ) | Resistance to antibiotics (Kanamycin, Neomycin), Resistance to diseases and pests (Fungi)
  • Grape vine modified for the expression of a marker gene
    | Bundesanstalt für Züchtungsforschung an Kulturpflanzen(BAZ) | Resistance to antibiotics (Kanamycin, Neomycin), Selectable marker genes and reporter genes
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health or on the environment are not expected.
EN
EN
EN
2 field sites in Germany, for details refer to the German LMO/GMO location register (https://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
EN
PCR-based methods to be developed according to the sequence of the transformation vector.
EN
Additional information
-   deliberate release, no placing on the market
-   field trial, not for human consumption or for feed purposes

-  There is no Summary Notification Information Format available on the Internet (WebSNIF) for B/DE/98/100
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1